palmatine has been researched along with allopurinol in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guo, L; Li, S; Liu, C; Ma, B; Qin, Y; Ren, J; Tang, Y; Wang, J; Wang, Y; Yang, X; Zhang, Y | 1 |
| Ai, G; Chen, J; Dou, Y; Huang, R; Qin, Z; Su, Z; Wu, X; Xie, J; Yang, X; Zhong, L | 1 |
2 other study(ies) available for palmatine and allopurinol
| Article | Year |
|---|---|
Ultrafiltration liquid chromatography combined with high-speed countercurrent chromatography for screening and isolating potential α-glucosidase and xanthine oxidase inhibitors from Cortex Phellodendri.
Topics: alpha-Glucosidases; Benzoxepins; Berberine; Berberine Alkaloids; Chromatography, High Pressure Liquid; Countercurrent Distribution; Drugs, Chinese Herbal; Enzyme Inhibitors; Glycoside Hydrolase Inhibitors; Limonins; Molecular Structure; Phellodendron; Ultrafiltration; Xanthine Oxidase | 2014 |
Hypouricemic and nephroprotective effects of palmatine from Cortex Phellodendri Amurensis: A uric acid modulator targeting Keap1-Nrf2/NLRP3 axis.
Topics: Animals; Creatinine; Hyperuricemia; Kelch-Like ECH-Associated Protein 1; Kidney; Mice; Molecular Docking Simulation; NF-E2-Related Factor 2; NLR Family, Pyrin Domain-Containing 3 Protein; Uric Acid; Xanthine Oxidase | 2023 |